Please assess the completion status of the following clinical trial:

Trial Title: Cardiovascular Disease Screening

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
* ELIGIBILITY CRITERIA:~No one will be excluded from this study based on race, gender, or ethnicity.~A. General Inclusion Criteria:~* Age greater than or equal to 18~* Capable of giving informed consent.~B. General Exclusion Criteria:~* Pregnant women (uncertain patients will have urine or blood testing).~* Decompensated heart failure (unable to lie flat in bed).~Test Specific Exclusion Criteria:~A. CT Exclusion Criteria (excludes contrast enhanced CT scan only):~* Allergy to iodinated contrast agent excludes contrast enhanced CT research studies.~* Multiple myeloma.~* Patients with severe kidney disease (eGFR less than 30 mL/min/1.73 m(2).~B. Beta Antagonist Exclusions (excluded the use of beta blocker only):~* Asthma or severe chronic lung disease/emphysema with regular use of inhaler.~* Decompensated heart failure.~C. MRI Exclusion Criteria (excludes MRI scan only):~* Cardiac pacemaker or implantable defibrillator.~* Cerebral aneurysm clip.~* Neural stimulator (e.g. TENS-Unit).~* Any type of ear implant.~* Metal in eye (e.g. from machining).~* Any implanted device (e.g. insulin pump, drug infusion device).~D. Exclusions from MRI contrast agents:~* Lactating women unless they are willing to discard breast milk for 24 hours.~* Severe kidney disease (less than 30 mL/min/1.73 m(2).~E. Vasodilator Exclusions (excludes some vasodilator stress testing):~* Asthma or chronic obstructive pulmonary disease (emphysema) actively treated with bronchodilators or leukotriene receptor antagonists (albuterol, seravent, atrovent, montelukast singulair, zafirlukast Accolate. These conditions only exclude adenosine and dipyridamole.~* Second degree (Type II) and third degree atrioventricular heart block.~F. Exclusions from Dobutamine stress MRI only:~* Severe problems with heart rhythms.~* Severe high blood pressure.~G. Exclusion criteria for atropine (given during dobutamine stress echocardiography when target heart rate not achievable with dobutamine alone).~* Narrow angle glaucoma.~* Known or suspected severe bladder outlet obstruction due to prostatic hypertrophy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with known or suspected cardiovascular disease (Type: None): Patients referred to protocol with known or suspected cardiovascular disease for further evaluation.

Based on this trial design, predict the completion outcome and termination type (if applicable).